Single-Atom Nanozymes Boost Hypoxia-Tolerant O2 Batteries

Hefei Institutes of Physical Science, Chinese Academy of Sciences

A research group led by Prof. WANG Hui from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences introduced an axial O atom-modulated Fe-N4 nanozymes for realizing efficient H2O2 Russell reaction to singlet oxygen (1O2) at hypoxic environment without external stimulus.

The study was published in Advanced Science.

1O2-elevated strategies show promise in inhibiting malignant tumor proliferation but face challenges such as inefficient and invasive external stimulation, hypoxic tumor microenvironments, and overexpressed redox species. Russell-type chemodynamic therapy (CDT) offers an oxygen-independent alternative to sensitize 1O2 generation, reducing normal tissue damage. However, only Cu-based and Mo-based nanomaterials have been used in Russell-type CDT, as other materials are inert. Single-atom enzymes (SAEs) with tunable electronic structures and uniform active sites offer potential for designing Russell-type nano reagents, but their symmetric electron distribution often results in suboptimal catalytic performance.

In this study, researchers designed a novel single-atom enzyme (SAE) featuring an axial O atom-engineered Fe-N4 structure. Density functional theory calculations revealed that the addition of the axial O atom shifts the d-band center of the Fe-N4 site towards the Fermi level, reducing activation energy and enhancing 1O2 selectivity and production efficiency. The five-coordinated O-Fe-N4 structure ensured clear catalytic activity.

Remarkably, the O-Fe-N4 nanozyme demonstrated self-cascade enzymatic performance, with glutathione oxidase-mimicking activity and reactive oxygen species-induced performance, preventing the loss of reactive oxygen species.

Both in vivo and in vitro experiments showed that the reduction of glutathione peroxidase 4 and lipid peroxidation collectively inhibited the proliferation of triple-negative breast cancer cells.

The O-Fe-N4 SAEs not only address the inherent limitations of the 1O2-elevated tumor therapy strategy but also provide valuable insights into the advanced catalytic efficiency of Fe-N4 catalysts, according to the team.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.